Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Chemistry and Biology of Ferroptosis
Brent R. Stockwell, Xuejun Jiang
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 365-375
Open Access | Times Cited: 290

Showing 26-50 of 290 citing articles:

Bufotalin induces ferroptosis in non-small cell lung cancer cells by facilitating the ubiquitination and degradation of GPX4
Wen Zhang, Baoping Jiang, Yunxin Liu, et al.
Free Radical Biology and Medicine (2022) Vol. 180, pp. 75-84
Closed Access | Times Cited: 106
Recent advances in small-molecule fluorescent probes for studying ferroptosis
Ya‐Lin Qi, Hairong Wang, Lili Chen, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7752-7778
Closed Access | Times Cited: 88
Hydropersulfides Inhibit Lipid Peroxidation and Protect Cells from Ferroptosis
Zijun Wu, Vinayak S. Khodade, Jean‐Philippe R. Chauvin, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 34, pp. 15825-15837
Closed Access | Times Cited: 87
Regulatory pathways and drugs associated with ferroptosis in tumors
Dan Wang, Le Tang, Yijie Zhang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 84
Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo
Tianli Luo, Qizhen Zheng, Leihou Shao, et al.
Angewandte Chemie International Edition (2022) Vol. 61, Iss. 39
Closed Access | Times Cited: 78
An overview of ferroptosis in non-alcoholic fatty liver disease
Shendong Wang, Zhaojun Liu, Jiafeng Geng, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113374-113374
Open Access | Times Cited: 70
Ferroptosis‐modulating small molecules for targeting drug‐resistant cancer: Challenges and opportunities in manipulating redox signaling
Solveigh C. Koeberle, Anna P. Kipp, Hermann Stuppner, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 3, pp. 614-682
Open Access | Times Cited: 54
Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience
Jaewang Lee, Jong‐Lyel Roh
Cancer Letters (2023) Vol. 559, pp. 216119-216119
Closed Access | Times Cited: 52
Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
Joseph M. Hendricks, Cody E. Doubravsky, Eddie Wehri, et al.
Cell chemical biology (2023) Vol. 30, Iss. 9, pp. 1090-1103.e7
Open Access | Times Cited: 52
A natural polyphenol activates and enhances GPX4 to mitigate amyloid-β induced ferroptosis in Alzheimer's disease
Prayasee Baruah, Hariharan Moorthy, Madhu Ramesh, et al.
Chemical Science (2023) Vol. 14, Iss. 35, pp. 9427-9438
Open Access | Times Cited: 46
Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases
Yao Xiang, Xiaohua Song, Dingxin Long
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 579-615
Open Access | Times Cited: 26
Mitochondrial dysfunction promotes aquaporin expression that controls hydrogen peroxide permeability and ferroptosis
Yuko Takashi, Kazuo Tomita, Yoshikazu Kuwahara, et al.
Free Radical Biology and Medicine (2020) Vol. 161, pp. 60-70
Open Access | Times Cited: 80
p53 Promoted Ferroptosis in Ovarian Cancer Cells Treated with Human Serum Incubated-Superparamagnetic Iron Oxides
Yunhan Zhang, Meihui Xia, Zizhen Zhou, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 283-296
Open Access | Times Cited: 75
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Tiansheng Li, Chao Mao, Xiang Wang, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 72
Cytochrome P450 reductase (POR) as a ferroptosis fuel
Pranavi Koppula, Li Zhuang, Boyi Gan
Protein & Cell (2021) Vol. 12, Iss. 9, pp. 675-679
Open Access | Times Cited: 66
Ferroptosis and Its Role in Epilepsy
Yuxiang Cai, Zhiquan Yang
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 66
Adipose tissue macrophage-derived exosomes induce ferroptosis via glutathione synthesis inhibition by targeting SLC7A11 in obesity-induced cardiac injury
Xin Zhao, Linjie Si, Jinhui Bian, et al.
Free Radical Biology and Medicine (2022) Vol. 182, pp. 232-245
Closed Access | Times Cited: 66
Ferroptosis, trophoblast lipotoxic damage, and adverse pregnancy outcome
Ofer Beharier, Kazuhiro Kajiwara, Yoel Sadovsky
Placenta (2021) Vol. 108, pp. 32-38
Open Access | Times Cited: 58
A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2‐positive breast cancer through regulating ferroptosis
Shengting Wang, Yufang Wang, Qian Li, et al.
Environmental Toxicology (2022) Vol. 37, Iss. 7, pp. 1597-1607
Closed Access | Times Cited: 53
Metabolic Intervention Nanoparticles for Triple‐Negative Breast Cancer Therapy via Overcoming FSP1‐Mediated Ferroptosis Resistance
Jie Yang, Zengguang Jia, Jun Zhang, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 13
Closed Access | Times Cited: 52
Novel Iron Oxide Nanoparticles Induce Ferroptosis in a Panel of Cancer Cell Lines
Roberto Fernández-Acosta, Claudia Iriarte‐Mesa, Daniel Alvarez-Almiñaque, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 3970-3970
Open Access | Times Cited: 51
Targeting ferroptosis: Paving new roads for drug design and discovery
Yilin Gu, Yizhe Li, Jiaxing Wang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115015-115015
Closed Access | Times Cited: 51
Ferroptosis: A New Road towards Cancer Management
Iqra Bano, Pavel Horký, Syed Qamar Abbas, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2129-2129
Open Access | Times Cited: 49
Cell-Specific Metabolic Reprogramming of Tumors for Bioactivatable Ferroptosis Therapy
Yanan Li, Menghuan Li, Li Liu, et al.
ACS Nano (2022) Vol. 16, Iss. 3, pp. 3965-3984
Closed Access | Times Cited: 48
Flavonoid 4,4′-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1/Nrf2/HMOX1 pathway and inhibiting FECH
Changmei Yang, Tianxiang Wang, Yujiao Zhao, et al.
Free Radical Biology and Medicine (2022) Vol. 188, pp. 14-23
Open Access | Times Cited: 48

Scroll to top